<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: Death Of A Sales Team? Wyeth Cuts 1,200 Reps</title>
	<atom:link href="http://www.pharmalot.com/2008/03/wyeth-cuts-1200-sales-reps/feed" rel="self" type="application/rss+xml" />
	<link>http://www.pharmalot.com/2008/03/wyeth-cuts-1200-sales-reps/</link>
	<description>News, Comment and Conversation</description>
	<pubDate>Fri, 10 Feb 2012 18:35:51 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.2</generator>
		<item>
		<title>By: Pharma News 5_2 &#171; Impactiviti blog</title>
		<link>http://www.pharmalot.com/2008/03/wyeth-cuts-1200-sales-reps/#comment-331970</link>
		<dc:creator>Pharma News 5_2 &#171; Impactiviti blog</dc:creator>
		<pubDate>Fri, 02 May 2008 18:22:42 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/2008/03/wyeth-cuts-1200-sales-reps/#comment-331970</guid>
		<description>[...] still more jobs are going, a Wyeth spokesman confirms. This follows an announcement last month that 1,240 sales positions would be eliminated as part of what Wyeth execs are calling ‘Project [...]</description>
		<content:encoded><![CDATA[<p>[...] still more jobs are going, a Wyeth spokesman confirms. This follows an announcement last month that 1,240 sales positions would be eliminated as part of what Wyeth execs are calling ‘Project [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Eelco</title>
		<link>http://www.pharmalot.com/2008/03/wyeth-cuts-1200-sales-reps/#comment-237735</link>
		<dc:creator>Eelco</dc:creator>
		<pubDate>Mon, 31 Mar 2008 11:51:33 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/2008/03/wyeth-cuts-1200-sales-reps/#comment-237735</guid>
		<description>Slowly firms are dismantling their sales forces. 
Can we see this as a next step in ending the marketing 'arms race'? 
They seem to get the point that if everyone decreases its sales force their impact will be the same (but with lower costs)...</description>
		<content:encoded><![CDATA[<p>Slowly firms are dismantling their sales forces.<br />
Can we see this as a next step in ending the marketing &#8216;arms race&#8217;?<br />
They seem to get the point that if everyone decreases its sales force their impact will be the same (but with lower costs)&#8230;</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Pharma News 3_29 &#171; Impactiviti blog</title>
		<link>http://www.pharmalot.com/2008/03/wyeth-cuts-1200-sales-reps/#comment-233616</link>
		<dc:creator>Pharma News 3_29 &#171; Impactiviti blog</dc:creator>
		<pubDate>Sat, 29 Mar 2008 12:36:23 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/2008/03/wyeth-cuts-1200-sales-reps/#comment-233616</guid>
		<description>[...] Wyeth cutting 1,200 sales reps - The positions are being eliminated as of Monday as part of a major companywide program announced two months ago to save money in the face of regulatory setbacks and generic competition. At the time, the drugmaker acknowledged plans to cut about 10 percent of its global workforce of 50,000 or so, and that sales reps were high on the list. Wyeth employs roughly 25,000 people in the US&#8230;more [...]</description>
		<content:encoded><![CDATA[<p>[...] Wyeth cutting 1,200 sales reps - The positions are being eliminated as of Monday as part of a major companywide program announced two months ago to save money in the face of regulatory setbacks and generic competition. At the time, the drugmaker acknowledged plans to cut about 10 percent of its global workforce of 50,000 or so, and that sales reps were high on the list. Wyeth employs roughly 25,000 people in the US&#8230;more [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Pharma Giles</title>
		<link>http://www.pharmalot.com/2008/03/wyeth-cuts-1200-sales-reps/#comment-232208</link>
		<dc:creator>Pharma Giles</dc:creator>
		<pubDate>Fri, 28 Mar 2008 19:10:21 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/2008/03/wyeth-cuts-1200-sales-reps/#comment-232208</guid>
		<description>The standard "10.0% percent must go".  Such original thinking.  McKinseys again?  Or just matching policies with Pfizer prior to the merger?</description>
		<content:encoded><![CDATA[<p>The standard &#8220;10.0% percent must go&#8221;.  Such original thinking.  McKinseys again?  Or just matching policies with Pfizer prior to the merger?</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Dan</title>
		<link>http://www.pharmalot.com/2008/03/wyeth-cuts-1200-sales-reps/#comment-231144</link>
		<dc:creator>Dan</dc:creator>
		<pubDate>Fri, 28 Mar 2008 05:40:23 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/2008/03/wyeth-cuts-1200-sales-reps/#comment-231144</guid>
		<description>While I wish this did not happen to this group, they will discover after termination that they will need to reacquire thier work ethic, if they had one.  Comparatively speaking, the job of a drug rep, from a physical or time consuming paradigm, is quite easy.</description>
		<content:encoded><![CDATA[<p>While I wish this did not happen to this group, they will discover after termination that they will need to reacquire thier work ethic, if they had one.  Comparatively speaking, the job of a drug rep, from a physical or time consuming paradigm, is quite easy.</p>
]]></content:encoded>
	</item>
</channel>
</rss>

<!-- Dynamic Page Served (once) in 0.154 seconds -->

